InvestorsHub Logo
Followers 0
Posts 13277
Boards Moderated 0
Alias Born 05/06/2016

Re: squidink post# 51773

Tuesday, 09/19/2023 2:24:10 AM

Tuesday, September 19, 2023 2:24:10 AM

Post# of 51975
But you're not.

I can only go by his track record with MEDS, his latest venture.


If you were going by his MEDS track record, there's no way you'd buy other Suren shell - it's sinking faster than the Skipper in quicksand.




It only spiked because a bunch of scarecrows drank Suren's Fool-Aid and believed they were heading to the Emerald City.



But there was no wizard, just an imposter behind a curtain.




Now that the hype is waning, the stock is failing.

One year ago an investor said

MT101
Tuesday, September 20

$5+ looks possible now


Looks like he was right - $5 does look possible now - on it's way down from $19.70 three months ago.

Meds went public at $6.50 per share on 2/13/2020. It's only 90¢ above that now and sinking fast.

Trxade Group also announced today the pricing of a firm commitment public offering of 806,452 shares of its common stock (post-Reverse Stock Split (as discussed below)) at a price to the public of $6.50 per share (post-Reverse Stock Split).





Maybe the Soleil Pharma entity is taking longer to get started. Maybe the initial strategy was delayed or didn't come together as initially planned.


Maybe Suren's a con man. Maybe you got played.

Maybe you need to grow a pair and admit you f'd up. 🍒

Bearish
Bearish